Article
PLA2G10 Gene Variants, sPLA2 Activity, and Coronary Heart Disease Risk.
Circulation. Cardiovascular genetics - 1 Apr 2015
Guardiola Montse, Exeter Holly J, Perret Claire, Folkersen Lasse, Van't Hooft Ferdinand, Eriksson Per, Franco-Cereceda Anders, Paulsson-Berne Gabrielle, Palmen Jutta, Li KaWah, Cooper Jackie A, Khaw Kay-Tee, Mallat Ziad, Ninio Ewa, Karabina Sonia-Athina, Humphries Steve E, Boekholdt S Matthijs, Holmes Michael V, Talmud Philippa J
Abstract excerpt
BACKGROUND: Observational studies report that secretory phospholipase A2 (sPLA2) activity is a marker for coronary heart disease (CHD) risk, and activity measures are thought to represent the composite activity of sPLA2-IIA, -V, and -X. The aim of this study was to use genetic variants of PLA2G10, encoding sPLA2-X, to investigate the contribution of sPLA2-X to the measure of sPLA2 activity and coronary heart...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
